Evidence map›Paper›PMID 39877837›Full record

ArticleBeilstein journal of nanotechnology2025

Instance maps as an organising concept for complex experimental workflows as demonstrated for (nano)material safety research.

Benjamin Punz, Maja Brajnik, Joh Dokler, Jaleesia D Amos, Litty Johnson, Katie Reilly, Anastasios G Papadiamantis, Amaia Green Etxabe, Lee Walker, Diego S T Martinez and 9 more

Abstract read
In one paragraph

Article in Beilstein journal of nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Nanoinformatics: spanning scales, systems and solutions.Beilstein journal of nanotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Benjamin PunzDepartment of Biosciences & Medical Biology, Paris Lodron University of Salzburg, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.ORCID https://orcid.org/0000-0001-9662-4739
Maja BrajnikSeven Past Nine d.o.o., Hribljane 10, 1380 Cerknica, Slovenia.ORCID https://orcid.org/0000-0002-7420-1388
Joh DoklerSeven Past Nine d.o.o., Hribljane 10, 1380 Cerknica, Slovenia.ORCID https://orcid.org/0000-0002-8053-8198
Jaleesia D AmosCenter for the Environmental Implications of Nano Technology (CEINT), Civil & Environmental Engineering, Duke University, Durham, North Carolina, 2770y8, USA.ORCID https://orcid.org/0000-0002-9769-4920
Litty JohnsonDepartment of Biosciences & Medical Biology, Paris Lodron University of Salzburg, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.
Katie ReillySchool of Geography, Earth and Environmental Sciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom.ORCID https://orcid.org/0000-0002-6054-0645
Anastasios G PapadiamantisSchool of Geography, Earth and Environmental Sciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom.ORCID https://orcid.org/0000-0002-1297-3104
Amaia Green EtxabeUK Centre for Ecology and Hydrology, Pollution, Wallingford, Oxfordshire, United Kingdom.ORCID https://orcid.org/0000-0003-4134-163X
Lee WalkerUK Centre for Ecology and Hydrology, Pollution, Wallingford, Oxfordshire, United Kingdom.
Diego S T MartinezBrazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, Brazil.
Steffi FriedrichsAcumenIST SRL, Etterbeek, Belgium.ORCID https://orcid.org/0000-0002-7276-892X
Klaus M WeltringGesellschaft für Bioanalytik Münster, Mendelstraße 17, 48149 Münster, Germany.
Nazende Günday-TüreliMyBiotech GmbH, Industriestrasse 1B, 66802 Überherrn, Germany.ORCID https://orcid.org/0000-0002-6310-4785
Claus SvendsenUK Centre for Ecology and Hydrology, Pollution, Wallingford, Oxfordshire, United Kingdom.
Christine Ogilvie HendrenDepartment of Geological and Environmental Sciences, Appalachian State University, Boone, USA.
Mark R WiesnerCenter for the Environmental Implications of Nano Technology (CEINT), Civil & Environmental Engineering, Duke University, Durham, North Carolina, 2770y8, USA.
Martin HimlyDepartment of Biosciences & Medical Biology, Paris Lodron University of Salzburg, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.ORCID https://orcid.org/0000-0001-5416-085X
Iseult LynchSchool of Geography, Earth and Environmental Sciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom.ORCID https://orcid.org/0000-0003-4250-4584
Thomas E ExnerSeven Past Nine GmbH, Rebacker 68, 79650 Schopfheim, Germany.ORCID https://orcid.org/0000-0002-1849-5246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanosafety assessment, which seeks to evaluate the risks from exposure to nanoscale materials, spans materials synthesis and characterisation, exposure science, toxicology, and computational approaches, resulting in complex experimental workflows and diverse data types. Managing the data flows, with a focus on provenance (who generated the data and for what purpose) and quality (how was the data generated, using which protocol with which controls), as part of good research output management, is necessary to maximise the reuse potential and value of the data. Instance maps have been developed and evolved to visualise experimental nanosafety workflows and to bridge the gap between the theoretical principles of FAIR (Findable, Accessible, Interoperable and Re-usable) data and the everyday practice of experimental researchers. Instance maps are most effective when applied at the study design stage to associate the workflow with the nanomaterials, environmental conditions, method descriptions, protocols, biological and computational models to be used, and the data flows arising from study execution. Application of the InstanceMaps tool (described herein) to research workflows of increasing complexity is presented to demonstrate its utility, starting from (i) documentation of a nanomaterial's synthesis, functionalisation, and characterisation, over (ii) assessment of a nanomaterial's transformations in complex media, (iii) description of the culturing of ecotoxicity model organisms

Indexed as

data collection and quality controldata provenanceexperimental workflow visualisationFAIRnanomaterial life cycle stagesstudy design

Identifiers

PMID39877837
PMCPMC11773194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.